- Home
- VRDN vs ALRM Comparison
VRDN vs ALRM Comparison
Compare VRDN & ALRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRDN | ALRM |
|---|---|---|
| Founded | 2006 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.6B |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | VRDN | ALRM |
|---|---|---|
| Price | $32.44 | $52.32 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 3 |
| Target Price | $39.73 | ★ $64.67 |
| AVG Volume (30 Days) | ★ 1.6M | 427.5K |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 1.77 |
| EPS | N/A | ★ 2.36 |
| Revenue | $70,789,000.00 | ★ $991,770,000.00 |
| Revenue This Year | $26,477.48 | $8.53 |
| Revenue Next Year | $6.23 | $4.12 |
| P/E Ratio | ★ N/A | $22.14 |
| Revenue Growth | ★ 23340.07 | 7.36 |
| 52 Week Low | $9.90 | $46.65 |
| 52 Week High | $33.34 | $68.54 |
Technical Indicators
Market Signals| Indicator | VRDN | ALRM |
|---|---|---|
| Relative Strength Index (RSI) | 65.20 | 55.74 |
| Support Level | $31.11 | $51.96 |
| Resistance Level | $33.29 | $53.29 |
| Average True Range (ATR) | 1.23 | 1.10 |
| MACD | -0.17 | 0.16 |
| Stochastic Oscillator | 69.57 | 58.34 |
Price Performance
Historical ComparisonAbout VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About ALRM Alarm.com Holdings Inc.
Alarm.com Holdings Inc has a cloud-based platform that offers an expansive suite of IoT solutions addressing world-wide opportunities in the residential, multi-family, small business and enterprise commercial markets. It has two reportable segments: Alarm.com & Other. The Alarm.com segment represents the cloud-based Software platforms for intelligently connected property & related solutions. The other segment is focused on researching, developing & offering residential & commercial automation solutions & energy management products & services in adjacent markets. The majority of revenue is from the Alarm.com segment. The platform allows home & business owners to secure their properties and automate & control an array of connected devices.